February 15, 2021 by Chain Drug Review
Comprehensive Addiction and Recovery Act, NACDS, opioid abuse crisis, Steve Anderson
February 15, 2021, News
ARLINGTON, Va. — The Drug Enforcement Administration’s (DEA’s) rulemaking that implements a 2016 law allowing for the partial filling of Schedule II controlled substances is a necessary step to help address the opioid abuse epidemic, yet changes are recommended to ensure success, according to the National Association of Chain Drug Stores. NACDS submitted comments this
November 9, 2020 by Chain Drug Review
opioid abuse crisis, U.S. Department of Justice (DOJ), Walmart
News, November 9, 2020
BENTONVILLE, Ark. — Walmart is suing the Department of Justice and the Drug Enforcement Administration (DEA), asking a federal court to clarify the roles and responsibilities of pharmacists and pharmacies under the Controlled Substances Act. The case is pending before the U.S. District Court for the Eastern District of Texas. Walmart states that the company
February 4, 2019 by Chain Drug Review
Hy-Vee, opioid abuse crisis
February 4, 2019, News
WEST DES MOINES, Iowa — To assist in combatting the national opioid epidemic, Hy-Vee Inc. has implemented a new controlled substance prescription policy. Since January 1, Hy-Vee pharmacies have not allowed a subsequent fill of a Schedule II controlled substance, or a refill of a Schedule III or Scheduled IV controlled substance more than 72
October 26, 2017 by Chain Drug Review
Commission on Combating Drug Addiction and the Opioid Epidemic, CVS Health, Healthcare Distribution Alliance, John Gray, John Hammergren, Larry Merlo, McKesson, Melania Trump, opioid abuse crisis, opioid abuse epidemic, President Donald Trump, President's Commission on Combating Drug Addiction and the Opioid Crisis, Stefano Pessina, video, Walgreens Boots Alliance
Leading Headlines, Pharmacy, Retail News, Videos
WASHINGTON — Following through on pledge made this summer, President Donald Trump has formally declared the nation’s growing opioid abuse epidemic as a public health emergency. In a press conference at the White House on Thursday, the president and First Lady Melania Trump announced the action, which has drawn plaudits from public officials and pharmacy
October 23, 2017 by Chain Drug Review
Commission on Combating Drug Addiction and the Opioid Epidemic, John Hammergren, McKesson, opioid abuse crisis, opioid epidemic, President Donald Trump
Leading Headlines, Pharmacy, Supplier News
SAN FRANCISCO — McKesson Corp. chairman and chief executive officer John Hammergren has endorsed President Donald Trump’s plan to designate the opioid abuse crisis as a national emergency. Trump this week is expected to formally declare the growing misuse and abuse of narcotic painkillers as a national emergency after saying this summer that he planned